# The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population

> **NCT05093478** · PHASE3 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 28 (actual)

## Conditions studied

- Non-allergic Rhinitis

## Interventions

- **DRUG:** Intranasal capsaicin
- **DRUG:** topical lidocaine

## Key facts

- **NCT ID:** NCT05093478
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-10
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05093478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05093478, "The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05093478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*